Methylene blue and monosodium glutamate improve neurologic signs after fluoroacetate poisoning.


Journal

Annals of the New York Academy of Sciences
ISSN: 1749-6632
Titre abrégé: Ann N Y Acad Sci
Pays: United States
ID NLM: 7506858

Informations de publication

Date de publication:
11 2020
Historique:
received: 31 01 2020
revised: 13 03 2020
accepted: 17 03 2020
pubmed: 15 4 2020
medline: 31 12 2020
entrez: 15 4 2020
Statut: ppublish

Résumé

Fluoroacetate (FA) is a tasteless, odorless, water-soluble metabolic poison with severe toxicological effects. Characterized in the mid-1900s, it has been used as a rodenticide but is comparably lethal to all mammals. Many countries have restricted its use, and modern-day accidental human exposures are rare, but recently, concerns have been raised about its application as a chemical weapon with no known antidote. A combined treatment of methylene blue (MB), an antioxidant, and monosodium glutamate (MSG), a precursor of the citric acid cycle substrate alpha-ketoglutarate, has been recommended as an effective countermeasure; however, no peer-reviewed articles documenting the efficacy of this therapy have been published. Using a rodent model, we assessed the effects of MB and MSG on the neurologic, cardiac, and pulmonary systems. Transcriptomic analysis was used to elucidate inflammatory pathway activation and guide bioassays, which revealed the advantages and disadvantages of these candidate countermeasures. Results show that MB and MSG can reduce neurologic signs observed in rats exposed to sodium FA and improve some effects of intoxication. However, while this strategy resolved some signs of intoxication, ultimately it was unable to significantly reduce lethality.

Identifiants

pubmed: 32285953
doi: 10.1111/nyas.14347
pmc: PMC7554062
mid: NIHMS1580372
doi:

Substances chimiques

Fluoroacetates 0
fluoroacetic acid AP1JV9U41M
Methylene Blue T42P99266K
Sodium Glutamate W81N5U6R6U

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

196-209

Subventions

Organisme : ODCDC CDC HHS
ID : AOD18015-001
Pays : United States

Informations de copyright

Published 2020. This article is a U.S. Government work and is in the public domain in the USA.

Références

Aust J Biol Sci. 1985;38(2):139-49
pubmed: 4051904
J Physiol. 1949 Dec;110(3-4):488-500
pubmed: 15406444
Science. 1945 Aug 31;102(2644):232-3
pubmed: 17778513
Arch Biochem Biophys. 1961 Apr;93:1-14
pubmed: 13702988
Forensic Sci Med Pathol. 2017 Dec;13(4):450-453
pubmed: 28975486
Anal Methods. 2018 Dec 14;10(46):5455-5590
pubmed: 30598702
Am J Ther. 2018 Nov/Dec;25(6):e756-e758
pubmed: 29668489
Cogent Biol. 2019;5(1):
pubmed: 31595219
Toxicon. 2017 Oct;137:54-57
pubmed: 28716647
Neuroscience. 2015 Aug 20;301:193-203
pubmed: 26047733
Toxicology. 2002 Dec 27;181-182:523-30
pubmed: 12505362
Food Chem Toxicol. 2018 Apr;114:145-154
pubmed: 29454866
Toxicol Lett. 2019 Sep 15;312:204-213
pubmed: 31047999
Arch Toxicol Suppl. 1983;6:228-31
pubmed: 6578726
J Appl Toxicol. 2006 Mar-Apr;26(2):148-61
pubmed: 16252258
J Food Prot. 2016 Feb;79(2):273-81
pubmed: 26818988
Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13699-703
pubmed: 8942997
Toxicol Lett. 2004 Aug 1;151(3):399-406
pubmed: 15261984
Proc R Soc Lond B Biol Sci. 1952 Feb 28;139(895):143-70
pubmed: 14911820
J Anaesthesiol Clin Pharmacol. 2010 Oct;26(4):517-20
pubmed: 21547182
Hum Exp Toxicol. 2010 Nov;29(11):903-13
pubmed: 20354062
Cell Tissue Res. 1977 Sep 14;183(1):1-23
pubmed: 922823
Vet Pathol. 2013 Nov;50(6):1022-7
pubmed: 23613492
Anesthesiology. 2005 Sep;103(3):556-66
pubmed: 16129981
Toxicology. 1979 Dec;15(1):43-53
pubmed: 542959
AANA J. 2008 Aug;76(4):271-4
pubmed: 18777811
J Clin Invest. 2018 Aug 31;128(9):3716-3726
pubmed: 30124471
Emerg Med Clin North Am. 2007 May;25(2):549-66; abstract xi
pubmed: 17482032
J Am Med Assoc. 1955 Dec 17;159(16):1529-32
pubmed: 13271109
Microb Ecol. 2016 Feb;71(2):494-504
pubmed: 26111963
Science. 1970 Dec 25;170(3965):1412-4
pubmed: 5481856
Arch Biochem Biophys. 1983 Sep;225(2):928-35
pubmed: 6625615
Arch Surg. 1999 Jun;134(6):666-9
pubmed: 10367878
Biochim Biophys Acta. 1971 Oct;252(1):83-91
pubmed: 5141830
Bull World Health Organ. 1973;48(4):469-77
pubmed: 4543551
Toxicol Sci. 2019 Jul 1;170(1):82-94
pubmed: 30907955

Auteurs

Vanessa E DeLey Cox (VE)

Pharmaceutical Sciences Department, U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland.

Matthew A Hartog (MA)

Pharmaceutical Sciences Department, U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland.

Erin Pueblo (E)

Pharmaceutical Sciences Department, U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland.

Michelle Racine (M)

Pharmaceutical Sciences Department, U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland.

Laura Jennings (L)

Pharmaceutical Sciences Department, U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland.

Justin Tressler (J)

Pharmaceutical Sciences Department, U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland.

Wing Y Tuet (WY)

Pharmaceutical Sciences Department, U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland.

Samuel Stone (S)

Pharmaceutical Sciences Department, U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland.

Samuel A Pierce (SA)

Pharmaceutical Sciences Department, U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland.

Lily Thompson (L)

Pharmaceutical Sciences Department, U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland.

Aliyah Dukes (A)

Pharmaceutical Sciences Department, U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland.

Heidi Hoard-Fruchey (H)

Pharmaceutical Sciences Department, U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland.

Benjamin Wong (B)

Pharmaceutical Sciences Department, U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland.

Bryan J McCranor (BJ)

Pharmaceutical Sciences Department, U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH